论文部分内容阅读
目的探讨功能性胃肠疾病治疗前后抑郁与焦虑情况。方法选择功能性胃肠疾病患者63例为观察组，50例健康志愿者为对照组。功能性胃肠疾病患者应用促胃动力药物+抗抑郁药。结果①功能性胃肠疾病患者各SCL-90因子评分均显著高于健康对照组（P＜0.01）；②与治疗前相比，SCL-90因子评分显著改善（P＜0.01）。且治疗后功能性胃肠疾病患者SAS评分及SDS评分均显著降低（P＜0.01）。结论联合应用抗消化不良药物及抗抑郁焦虑药物可以显著改善患者抑郁或焦虑状态。“,”Objective To investigate the FGID depression and anxiety situation before and after treatment. Methods 63 cases of patients with FGID in the observation group, 50 healthy volunteers as control group. FGID patients were treated with prokinetic drugs + antidepressants. Results 1.In patients with FGID, SCL-90 factor scores were significantly higher than the control (P<0.01) 2 compared with before treatment, SCL-90 factor scores significantly improved (P<0.01). And the SAS scores and SDS scores were significantly lower (P<0.01). Conclusions Combined application of anti-indigestion drug and antidepressant anxiety drugs can significantly improved the depression or anxiety state of FGID patients.